Australian watchdog takes GlaxoSmithKline, Novartis units to court


REUTERS: The Australian Competition and Consumer Commission on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products. The ACCC alleged that the companies tried to market their two pain relief products, Osteo Gel and Emulgel, as having different levels of impact in treating osteoarthritis, when in fact they are "identically formulated".



from Biotech News